CEBP Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van den Brandt, P. A.
Right arrow Articles by Goldbohm, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van den Brandt, P. A.
Right arrow Articles by Goldbohm, R. A.
Cancer Epidemiology Biomarkers & Prevention Vol. 12, 866-871, September 2003
© 2003 American Association for Cancer Research

Toenail Selenium Levels and the Subsequent Risk of Prostate Cancer

A Prospective Cohort Study1

Piet A. van den Brandt2, Maurice P. A. Zeegers, Peter Bode and R. Alexandra Goldbohm

Department of Epidemiology, Maastricht University, 6200 MD Maastricht [P. A. v. d. B., M. P. A. Z.]; Interfaculty Reactor Institute, Delft University of Technology, Delft [P. B.]; and Department of Epidemiology, TNO Nutrition and Food Research, Zeist [R. A. G.], the Netherlands

Results of a randomized controlled trial have suggested a protective effect of selenium against prostate cancer. Few other prospective studies have been conducted to confirm or refute this. The association between prostate cancer and baseline toenail selenium level was evaluated in the Netherlands Cohort Study, conducted among 58,279 men, aged 55–69 years at entry. In September 1986, the cohort members completed a questionnaire on risk factors for cancer and provided toenail clippings for determination of baseline selenium status. After 6.3 years of follow-up, 540 incident prostate carcinoma cases and 1,211 subcohort members with complete toenail selenium data were available for case-cohort analyses. In multivariate survival analysis, an inverse association between toenail selenium level and prostate cancer risk was observed. Incidence rate ratios in increasing selenium quintiles were 1.00 (ref), 1.05, 0.69, 0.75, and 0.69 (95% confidence interval, 0.48–0.99), respectively (P-trend = 0.008). This association persisted after exclusion of cases diagnosed during early follow-up. The inverse association was more pronounced in ex-smokers than current smokers, and unclear in never-smokers. Analysis of effect modification by intake of antioxidant vitamins C, E, and the carotenoids {alpha}-carotene, ß-carotene, ß-cryptoxanthin, lycopene, and lutein/zeaxanthin showed a strong, significant interaction with ß-cryptoxanthin, and to a lesser extent with vitamin C. These results confirm the hypothesis that higher selenium intake may reduce prostate cancer risk. Future research on optimum dose level is needed.




This article has been cited by other articles:


Home page
Bioscience HorizonsHome page
E. J. Adams
A dynamic website for a government/industry-funded project exploring biofortification of wheat with selenium
Bioscience Horizons, March 1, 2008; 1(1): 75 - 84.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
U. Peters, C. B Foster, N. Chatterjee, A. Schatzkin, D. Reding, G. L Andriole, E D. Crawford, S. Sturup, S. J Chanock, and R. B Hayes
Serum selenium and risk of prostate cancer--a nested case-control study
Am. J. Clinical Nutrition, January 1, 2007; 85(1): 209 - 217.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
V. Diwadkar-Navsariwala, G. S. Prins, S. M. Swanson, L. A. Birch, V. H. Ray, S. Hedayat, D. L. Lantvit, and A. M. Diamond
Selenoprotein deficiency accelerates prostate carcinogenesis in a transgenic model
PNAS, May 23, 2006; 103(21): 8179 - 8184.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. L. Sabichi, J. J. Lee, R. J. Taylor, I. M. Thompson, B. J. Miles, C. M. Tangen, L. M. Minasian, L. L. Pisters, J. R. Caton, J. W. Basler, et al.
Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group Study.
Clin. Cancer Res., April 1, 2006; 12(7 Pt 1): 2178 - 2184.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. M. Chan, P. H. Gann, and E. L. Giovannucci
Role of Diet in Prostate Cancer Development and Progression
J. Clin. Oncol., November 10, 2005; 23(32): 8152 - 8160.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
P. R. Taylor and P. Greenwald
Nutritional Interventions in Cancer Prevention
J. Clin. Oncol., January 10, 2005; 23(2): 333 - 345.
[Abstract] [Full Text] [PDF]


Home page
Integr Cancer TherHome page
M. F. McCarty
Targeting Multiple Signaling Pathways as a Strategy for Managing Prostate Cancer: Multifocal Signal Modulation Therapy
Integr Cancer Ther, December 1, 2004; 3(4): 349 - 380.
[Abstract] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
A. D. Dangour, V. L. Sibson, and A. E. Fletcher
Hormones and Supplements: Do They Work?: Micronutrient Supplementation in Later Life: Limited Evidence for Benefit
J. Gerontol. A Biol. Sci. Med. Sci., July 1, 2004; 59(7): B659 - B673.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
P. R. Taylor, H. L. Parnes, and S. M. Lippman
Science Peels the Onion of Selenium Effects on Prostate Carcinogenesis
J Natl Cancer Inst, May 5, 2004; 96(9): 645 - 647.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
H. Li, M. J. Stampfer, E. L. Giovannucci, J. S. Morris, W. C. Willett, J. M. Gaziano, and J. Ma
A Prospective Study of Plasma Selenium Levels and Prostate Cancer Risk
J Natl Cancer Inst, May 5, 2004; 96(9): 696 - 703.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2003 by the American Association for Cancer Research.